A comprehensive view of Cancer. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Consumer Wellness Market Intelligence Service.
INTERNATIONAL PATENT: AMGEN INC. FILES APPLICATION FOR "TETHERED HETEROCYCLIC INHIBITORS OF KRAS G12C MUTANT PROTEINS AND USES THEREOF"
Published:
April 17, 2024
by U.S. Fed News
|
INTERNATIONAL PATENT: AMGEN INC. FILES APPLICATION FOR "COMBINATION THERAPIES COMPRISING T-CELL REDIRECTING THERAPIES AND AGONISTIC ANTI-IL-2R ANTIBODIES OR FRAGMENTS THEREOF"
Published:
April 17, 2024
by U.S. Fed News
|
INTERNATIONAL PATENT: REGENERON PHARMACEUTICALS, INC. FILES APPLICATION FOR "METHODS OF TREATING CANCER WITH BISPECIFIC EGFR X CD28 ANTIBODIES ALONE OR IN COMBINATION WITH ANTI-PD-1 ANTIBODIES"
Published:
April 17, 2024
by U.S. Fed News
|
US Patent Issued to Regeneron Pharmaceuticals on April 16 for "Bispecific antigen binding molecules that bind HER2, and methods of use thereof" (New York, Delaware Inventors)
Published:
April 17, 2024
by U.S. Fed News
|
US Patent Issued to TORAY INDUSTRIES, National Cancer Center on April 16 for "Prostate cancer detection kit or device, and detection method" (Japanese Inventors)
Published:
April 17, 2024
by U.S. Fed News
|
Ask us about our Consumer Wellness market view